Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000912801 | SCV001057920 | likely benign | not provided | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505345 | SCV002812450 | likely benign | Focal segmental glomerulosclerosis 6 | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000912801 | SCV005214974 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003933005 | SCV004750066 | likely benign | MYO1E-related disorder | 2019-06-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |